End-to-End View of Covid Vaccine Manufacture and Distribution

Pfizer logov2

Speakers:
Kevin Nepveux, M.S.
VP, Launch Excellence
Pfizer

Kevin Nepveux is Vice President, Launch Excellence. Kevin’s responsibilities include the creation of new technology and manufacturing modalities to support the co-development and launch processes.  This function leads PGS Co-Development Teams and provides a single point of accountability for new product activities within PGS and to our internal stakeholders (WRD, Commercial Business Units). He joined Pfizer in 1980 at Groton, Connecticut, as a Production Supervisor in the penicillin area.  In 1985, he moved to R&D to work on azithromycin, danofloxacin and other projects.  Kevin managed the Groton Active Pharmaceutical Ingredient pilot plant until 1995, when he returned to manufacturing in a technical services position.  As manufacturing grew and became more specialized, he focused on technical and project management support for new products as part of Global Manufacturing Services (GMS).  For several years, he led a group within GMS working with Pfizer Global R&D and the PGS launch sites to develop and introduce new products. In his current position, Kevin leads the Global Technology Services organization in providing technical leadership and support for new and marketed products for all PGS customers.

Previous to his current role Kevin was Vice President, Global Technology Services. Kevin holds a B.S. in Chemical Engineering from the University of Delaware and an M.S. in Computer Science from Rensselaer Polytechnic Institute

 

James Jean, M.B.A.
Director, Temperature Control Logistics,
Pfizer Global Supply 

James Jean is the Director of Temperature Control Logistics for Pfizer Global Supply Chain. James leads a global team of engineers and technical subject matter experts responsible for Pfizer Global Supply Chain's temperature sensitive product portfolio. Most recently, James has successfully led his team in developing supply chain capabilities for the launch of the Pfizer COVID-19 Vaccine across many global markets.

ATTN:
Questions are being collected in advance for our Georgia Tech, October 21, Pfizer lecture with Kevin Nepveux and James Jean.
Submit your question(s) HERE.